(GILD) Gilead Sciences - Performance 63.5% in 12m
Compare GILD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
63.26%
#7 in Group
Rel. Strength
93.13%
#550 in Universe
Total Return 12m
63.51%
#20 in Group
Total Return 5y
62.13%
#26 in Group
P/E 275
95th Percentile in Group
P/E Forward 13.2
48th Percentile in Group
PEG 0.22
67th Percentile in Group
FCF Yield 7.12%
98th Percentile in Group
12m Total Return: GILD (63.5%) vs XBI (-7.2%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.45% | 25.1% | 163% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
3.06% | 25.7% | 43.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.4% | 5.51% | 37.4% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-3.34% | 9.2% | 33.3% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-3.25% | 13.2% | -1.03% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-12% | -23.9% | 3.63% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-8.87% | 30.5% | -10.1% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
-2.43% | -17.2% | 17.1% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: GILD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GILD
Total Return (including Dividends) | GILD | XBI | S&P 500 |
---|---|---|---|
1 Month | -1.15% | -12.59% | -8.16% |
3 Months | 14.20% | -14.87% | -12.80% |
12 Months | 63.51% | -7.16% | 6.85% |
5 Years | 62.13% | -19.64% | 100.40% |
Trend Score (consistency of price movement) | GILD | XBI | S&P 500 |
1 Month | -67.8% | -66.6% | -70.9% |
3 Months | 42.2% | -92.4% | -90.1% |
12 Months | 97.3% | -30.3% | 62.2% |
5 Years | 78.3% | -53.2% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #51 | 13.1% | 7.63% |
3 Month | #17 | 34.2% | 31.0% |
12 Month | #21 | 76.1% | 53.0% |
5 Years | #27 | 102% | -19.1% |
FAQs
Does GILD Gilead Sciences outperforms the market?
Yes,
over the last 12 months GILD made 63.51%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months GILD made 14.20%, while XBI made -14.87%.
Over the last 3 months GILD made 14.20%, while XBI made -14.87%.
Performance Comparison GILD vs Indeces and Sectors
GILD vs. Indices GILD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.77% | 7.01% | 30.6% | 56.7% |
US NASDAQ 100 | QQQ | 2.79% | 8.26% | 31.6% | 56.7% |
US Dow Jones Industrial 30 | DIA | 2.72% | 6.71% | 29.5% | 59.4% |
German DAX 40 | DAX | -0.32% | 5.71% | 12.1% | 45.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.85% | 2.58% | 28.2% | 55.4% |
Hongkong Hang Seng | HSI | -3.28% | 3.81% | 25.9% | 46.2% |
India NIFTY 50 | INDA | -4.80% | -3.80% | 24.6% | 59.7% |
Brasil Bovespa | EWZ | -4.18% | 0.11% | 25.2% | 73.4% |
GILD vs. Sectors GILD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.61% | 7.17% | 21.6% | 48.5% |
Consumer Discretionary | XLY | 1.29% | 7.72% | 26.7% | 53.4% |
Consumer Staples | XLP | -1.65% | -4.73% | 20.0% | 51.2% |
Energy | XLE | -3.12% | 11.2% | 29.9% | 75.6% |
Financial | XLF | 0.07% | 4.81% | 20.7% | 46.3% |
Health Care | XLV | 1.75% | 7.07% | 31.4% | 65.1% |
Industrial | XLI | 1.20% | 6.04% | 29.9% | 59.3% |
Materials | XLB | -0.84% | 4.81% | 35.9% | 70.4% |
Real Estate | XLRE | -1.62% | 2.20% | 27.9% | 47.9% |
Technology | XLK | 4.04% | 10.4% | 38.2% | 63.7% |
Utilities | XLU | -0.57% | -0.93% | 24.2% | 41.8% |
Aerospace & Defense | XAR | 2.13% | 4.22% | 21.8% | 42.3% |
Biotech | XBI | -1.60% | 11.4% | 42.5% | 70.7% |
Homebuilder | XHB | -1.36% | 6.83% | 43.3% | 71.5% |
Retail | XRT | -2.44% | 4.47% | 32.5% | 68.0% |